MarketPulse — Real-Time Financial News & Market Analysis

Sweetgreen's $655M valuation offers theoretical millionaire potential, but deteriorating same-store sales and mounting losses suggest the turnaround remains unproven.

Driven Brands faces securities lawsuit after revealing material accounting errors spanning 2023-2024. Stock crashed 40% to $9.99 on disclosure of internal control failures.

BridgeBio Pharma jumps 12.6% after William Blair initiates coverage with Outperform rating, citing accelerating product launches and robust rare-disease pipeline.

Law firm investigates $BNTX following €305M Q4 loss, plunging COVID vaccine demand, and planned founder departure, examining potential securities law violations.

Boston Scientific faces class action lawsuit alleging misleading statements about electrophysiology market position, with stock down 17% after missing earnings guidance.

BioXcel Therapeutics raises $8M via direct offering of 4.5M shares at $1.739/share, with warrant modifications agreed, closing expected March 2026.

Freshworks executive sells $275K in shares via pre-planned trading program, but analyst maintains buy rating citing 16% revenue growth and improving profitability.

Micron Technology stock rallies 4.82% after announcing expanded partnership with Applied Materials to accelerate AI memory chip development amid surging data center demand.

ResMed trades at a 25% valuation discount despite 11% revenue growth and expanding digital health operations in 140+ countries, though Medicare reimbursement risks persist.

CoreWeave stock tumbled 24% post-IPO despite 168% revenue growth and $66.8B backlog, raising questions about valuation sustainability amid rising capital costs.

Apis Capital Advisors liquidates entire $17.6M stake in GEO Group amid operational decline, negative cash flow, and mounting debt pressures.

Nvidia launches NemoClaw, an open-source AI agent platform with security features, partnering with Alphabet, Salesforce, and Adobe. AI agents could drive 1,000x token consumption growth, benefiting Nvidia's GPU business.

Market concentration in mega-cap stocks mirrors 1930s-60s patterns. Research shows concentration doesn't predict risk or returns.

Cohesity and ServiceNow integrate platforms to provide immutable recovery for enterprise AI agents, launching integrated capabilities in late 2026.

Uber and Airbnb offer attractive valuations with strong profitability, trading at 22.9x and 26.3x forward P/E respectively, making both viable long-term investments.

Bunge Global targets $15 EPS by 2030 and authorizes $3B buybacks, but 2026 guidance of $7.50-$8 trails analyst expectations.

$AUR surges 15% on fleet expansion plans to 200+ trucks by 2026, but faces $190-220M quarterly cash burn and no profitability until 2028.

Semiconductor leaders Nvidia, AMD, Broadcom, Micron, and TSMC positioned to benefit from $700B AI data center spending wave through 2026.

PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.

Global pharmaceutical microbiology QC testing market projected to grow from $5.08B in 2025 to $17.65B by 2035, driven by automation and AI adoption.